These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 16472872)

  • 1. Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance.
    van der Meulen KM; Favoreel HW; Pensaert MB; Nauwynck HJ
    Vet Immunol Immunopathol; 2006 May; 111(1-2):31-40. PubMed ID: 16472872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH; Townsend HG; Hannant D
    Vet Immunol Immunopathol; 2006 May; 111(1-2):15-30. PubMed ID: 16476492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome.
    Osterrieder N; Van de Walle GR
    Vet Microbiol; 2010 Jun; 143(1):21-8. PubMed ID: 20202764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
    Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR; Studdert MJ
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine responses to EHV-1 infection in immune and non-immune ponies.
    Coombs DK; Patton T; Kohler AK; Soboll G; Breathnach C; Townsend HG; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):109-16. PubMed ID: 16473413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of equine herpesvirus-1 and equine herpesvirus-4 infections in equidae species in Turkey as determined by ELISA and multiplex nested PCR.
    Ataseven VS; Dağalp SB; Güzel M; Başaran Z; Tan MT; Geraghty B
    Res Vet Sci; 2009 Apr; 86(2):339-44. PubMed ID: 18649902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract.
    Breathnach CC; Yeargan MR; Timoney JF; Allen GP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):117-25. PubMed ID: 16472871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
    Van de Walle GR; May MA; Peters ST; Metzger SM; Rosas CT; Osterrieder N
    Vaccine; 2010 Jan; 28(4):1048-55. PubMed ID: 19897066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro cytotoxicity of serum and peripheral blood leukocytes for equine herpesvirus type 1-infected target cells.
    Wilks CR
    Am J Vet Res; 1977 Jan; 38(1):117-21. PubMed ID: 189645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and antibody responses to equine herpesviruses 1 and 4.
    Studdert MJ
    J Am Vet Med Assoc; 1995 Sep; 207(6):698-701. PubMed ID: 7657564
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
    Platt R; Sponseller BA; Chiang YW; Roth JA
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)--epidemiology, disease and immunoprophylaxis: a brief review.
    Patel JR; Heldens J
    Vet J; 2005 Jul; 170(1):14-23. PubMed ID: 15993786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One way protection between equid herpesvirus 1 and 4 in vivo.
    Edington N; Bridges CG
    Res Vet Sci; 1990 Mar; 48(2):235-9. PubMed ID: 2159176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
    Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the major glycoproteins of equine herpesviruses 4 and 1 and asinine herpesvirus 3 using monoclonal antibodies.
    Crabb BS; Allen GP; Studdert MJ
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2075-82. PubMed ID: 1716650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.